Normal
10th - 11th March 2022

6th Annual MarketsandMarkets Next Gen Immuno-Oncology Congress- UK

ILEC Conference Center and IBIS London Earls Court, 47 Lillie Road, London, SW6 1UD

The treatment options for cancer, such as chemotherapies and radiation therapy, although have more side effects, are more widely used as compared to immunotherapies. The former are all based on destroying cancer cells by irradiation, chemotherapy, or surgery. While they can effectively kill or remove cancer cells, the use of these treatments is often limited because they tend to destroy healthy cells in large numbers as well. As immunotherapies involve the mechanism of enhancing the body’s own immunity using man-made proteins such as monoclonal antibodies, they are accepted worldwide over other treatment options.

Our 6th Annual MarketsandMarkets Next Gen Immuno-Oncology Congress to be held on 10th-11th March 2022 in London, UK would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors. This congress would also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccines development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions.

WHAT TO EXPECT
Key Highlights
  • Updates in development of ADC’s and Bispecific Ab’s
  • Immune Checkpoint Inhibitors and Combinations
  • Preclinical and Translational Immuno-Oncology Developments (Preclinical models for Immune checkpoint modulators)
  • Biomarkers and Personalized Medicine in IO
  • CAR-T Cell therapy, TCR Based-Cell Therapy
  • Tumor microenvironment
  • Oncolytic Viruses
  • Personalized Cancer Immunotherapy
Who Should Attend?

CSO, Director, VP, Head, Senior Investigator, Manager, Principal Scientist, Team Leader, Group Leaders, Professors, Assistant Professors, Research fellows, PhDs working on

  • Monoclonal and Bispecific Antibodies
  • Cell Therapy
  • Immune Checkpoint Inhibitors
Why attend?
  • Exclusive conference to learn about antibodies, cellular therapy and immune-checkpoint research under one roof
  • Find out new case studies of immune-oncology projects in development
  • Contribute to interactive roundtables with your peers to deliberate key topics most relevant to you
  • Explore the latest platforms and technologies on the market for development
  • Discuss the best tool for your research in immune-oncology
  • Share your work and achievements with your industry peers in the Poster Session
CONFERENCE AGENDA
CONFERENCE SPEAKERS
Speakers
Ann Ager

Ann Ager

Professor, Cellular Immunity and Immunotherapy
Cardiff University

Ann Ager

Professor, Cellular Immunity and Immunotherapy
Cardiff University
Stefan Gluck

Stefan Gluck

Ex- Vice President, Global Head Franchise Oncology
Regeneron

Stefan Gluck

Ex- Vice President, Global Head Franchise Oncology
Regeneron
Mahendra Deonarain

Mahendra Deonarain

Chief Executive and Science Officer
Antikor Biopharma

Mahendra Deonarain

Chief Executive and Science Officer
Antikor Biopharma
Mark Throsby

Mark Throsby

Chief Scientific Officer
Gadeta BV

Mark Throsby

Chief Scientific Officer
Gadeta BV
 Sophie Watcham

Sophie Watcham

Scientist
Isogenica

Sophie Watcham

Scientist
Isogenica
Oystein Rekdal

Oystein Rekdal

CEO
Lytix Biopharma

Oystein Rekdal

CEO
Lytix Biopharma
Kenji Hashimoto

Kenji Hashimoto

Chief Medical Officer
Crescendo Biologics

Kenji Hashimoto

Chief Medical Officer
Crescendo Biologics
Anat Globerson Levin

Anat Globerson Levin

Director Immunology Lab, R&D
Tel-Aviv Sourasky Medical Center

Anat Globerson Levin

Director Immunology Lab, R&D
Tel-Aviv Sourasky Medical Center
SPONSORS
Gold
example-image

Thermo Fisher Scientific

example-image

Proteome Sciences

Silver
example-image

PHC Group

example-image

Epredia

example-image

Lonza

Speaking Partner
example-image

HalioDx

example-image

Kiromic Biopharma

example-image

TransCure bioServices

example-image

QIAGEN

Exhibition Partner
example-image

Champions Oncology

example-image

Myriad RBM

example-image

Proteintech

Meeting Partner
example-image

Larvol

PARTNERS
Supporting Association
MabDesign

MabDesign

Media Partners
example-image

Bentham Science

LOCATION
ILEC Conference Center and IBIS London Earls Court, 47 Lillie Road, London, SW6 1UD
About the Hotel

PAST EVENT GALLERY